Ercros Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Ercros wird ein jährliches Gewinn- und Umsatzwachstum von 48.5% bzw. 10.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 1.8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 6.7% betragen.

Wichtige Informationen

48.5%

Wachstumsrate der Gewinne

1.8%

EPS-Wachstumsrate

Chemicals Gewinnwachstum	21.5%
Wachstumsrate der Einnahmen	10.4%
Zukünftige Eigenkapitalrendite	6.7%
Analystenabdeckung	Low
Zuletzt aktualisiert	15 Oct 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Is Ercros, S.A.'s (BME:ECR) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Jan 05

Calculating The Intrinsic Value Of Ercros, S.A. (BME:ECR)

Dec 18

Shareholders Of Ercros (BME:ECR) Must Be Happy With Their 257% Total Return

Nov 29

Gewinn- und Umsatzwachstumsprognosen

BME:ECR - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	822	26	18	N/A	1
12/31/2025	812	23	13	N/A	2
12/31/2024	731	4	4	N/A	1
9/30/2024	657	14	N/A	N/A	N/A
6/30/2024	657	12	18	39	N/A
3/31/2024	691	18	N/A	N/A	N/A
12/31/2023	726	29	30	55	N/A
9/30/2023	815	21	N/A	N/A	N/A
6/30/2023	909	38	38	65	N/A
3/31/2023	980	66	N/A	N/A	N/A
12/31/2022	1,026	71	45	81	N/A
9/30/2022	1,033	68	N/A	N/A	N/A
6/30/2022	962	79	37	75	N/A
3/31/2022	893	52	N/A	N/A	N/A
12/31/2021	790	49	36	70	N/A
9/30/2021	714	28	N/A	N/A	N/A
6/30/2021	652	22	38	73	N/A
3/31/2021	590	14	N/A	N/A	N/A
12/31/2020	571	6	40	75	N/A
9/30/2020	573	18	N/A	N/A	N/A
6/30/2020	603	25	36	69	N/A
3/31/2020	645	28	N/A	N/A	N/A
12/31/2019	671	31	22	59	N/A
9/30/2019	682	26	N/A	N/A	N/A
6/30/2019	681	27	-6	30	N/A
3/31/2019	679	39	N/A	N/A	N/A
12/31/2018	672	45	6	48	N/A
9/30/2018	680	47	N/A	N/A	N/A
6/30/2018	676	49	N/A	75	N/A
3/31/2018	682	45	N/A	N/A	N/A
12/31/2017	681	45	N/A	44	N/A
9/30/2017	663	52	N/A	N/A	N/A
6/30/2017	644	49	N/A	21	N/A
3/31/2017	626	46	N/A	N/A	N/A
12/31/2016	603	45	N/A	38	N/A
9/30/2016	608	29	N/A	N/A	N/A
6/30/2016	613	21	N/A	43	N/A
3/31/2016	620	15	N/A	N/A	N/A
12/31/2015	618	7	N/A	14	N/A
9/30/2015	609	-3	N/A	N/A	N/A
6/30/2015	612	-3	N/A	1	N/A
3/31/2015	606	-4	N/A	N/A	N/A
12/31/2014	604	-7	N/A	10	N/A
9/30/2014	608	4	N/A	N/A	N/A
6/30/2014	608	4	N/A	53	N/A
3/31/2014	617	4	N/A	N/A	N/A
12/31/2013	625	0	N/A	24	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: ECRDas prognostizierte Gewinnwachstum (48.5% pro Jahr) liegt über der Sparquote (1.8%).

Ertrag vs. Markt: ECRDie Erträge des Unternehmens (48.5% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Spanish (9% pro Jahr).

Hohe Wachstumserträge: ECREs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: ECRDie Einnahmen des Unternehmens (10.4% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Spanish (4.8% pro Jahr).

Hohe Wachstumseinnahmen: ECRDie Einnahmen des Unternehmens (10.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: ECRDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (6.7%).

Ercros Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates fall by 14%

Consensus EPS estimates fall by 33%, revenue upgraded

Consensus EPS estimates fall by 32%

Recent updates

Third quarter 2024 earnings released

Consensus EPS estimates fall by 14%

Second quarter 2024 earnings released

Upcoming dividend of €0.078 per share

First quarter 2024 earnings released

Consensus EPS estimates fall by 33%, revenue upgraded

Now 25% overvalued after recent price rise

Bondalti Ibérica launched a public takeover offer to acquire Ercros, S.A. (BME:ECR) for €340 million .

Estimating The Intrinsic Value Of Ercros, S.A. (BME:ECR)

Full year 2023 earnings: Revenues miss analyst expectations

New minor risk - Share price stability

At €2.75, Is It Time To Put Ercros, S.A. (BME:ECR) On Your Watch List?

Ercros, S.A. to Report Q3, 2024 Results on Nov 15, 2024

Consensus EPS estimates fall by 32%

Here's Why Ercros (BME:ECR) Has A Meaningful Debt Burden

New major risk - Revenue and earnings growth

Ercros, S.A. to Report Q3, 2023 Results on Nov 08, 2023

New minor risk - Profit margin trend

Second quarter 2023 earnings released

Insufficient new directors

New major risk - Share price stability

Ercros, S.A. to Report First Half, 2023 Results on Aug 31, 2023

Upcoming dividend of €0.12 per share at 4.8% yield

Ercros, S.A., Annual General Meeting, Jun 15, 2023

Now 22% undervalued after recent price drop

Here's Why Ercros (BME:ECR) Can Manage Its Debt Responsibly

Full year 2022 earnings released: EPS: €0.64 (vs €0.43 in FY 2021)

Ercros, S.A. to Report Fiscal Year 2022 Results on Feb 28, 2023

Ercros, S.A. to Report Fiscal Year 2022 Results on Feb 22, 2023

Now 20% undervalued after recent price drop

Ercros, S.A. to Report Q3, 2022 Results on Nov 15, 2022

Ercros, S.A. to Report Q2, 2022 Results on Aug 31, 2022

Second quarter 2022 earnings released

Ercros, S.A. to Report First Half, 2022 Results on Jul 28, 2022

Upcoming dividend of €0.069 per share

Now 23% undervalued

Ercros, S.A., Annual General Meeting, Jun 09, 2022

Ercros, S.A. to Report Q1, 2022 Results on May 14, 2022

Ercros (BME:ECR) Will Be Hoping To Turn Its Returns On Capital Around

Now 23% undervalued

Why Ercros, S.A. (BME:ECR) Could Be Worth Watching

Third quarter 2021 earnings released

Should You Investigate Ercros, S.A. (BME:ECR) At €3.71?

A Look At The Fair Value Of Ercros, S.A. (BME:ECR)

Here's Why Ercros (BME:ECR) Has A Meaningful Debt Burden

Investor sentiment improved over the past week

Should Ercros, S.A. (BME:ECR) Be Part Of Your Dividend Portfolio?

Should You Think About Buying Ercros, S.A. (BME:ECR) Now?

Full year 2020 earnings released: EPS €0.061 (vs €0.29 in FY 2019)

Revenue beats expectations, earnings disappoint

Is Ercros (BME:ECR) A Future Multi-bagger?

New 90-day high: €2.48

Here's Why Ercros (BME:ECR) Has A Meaningful Debt Burden

Ercros, S.A. to Report Fiscal Year 2020 Results on Feb 27, 2021

Read This Before Buying Ercros, S.A. (BME:ECR) For Its Dividend

New 90-day high: €2.44

Is Ercros, S.A.'s (BME:ECR) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Calculating The Intrinsic Value Of Ercros, S.A. (BME:ECR)

Shareholders Of Ercros (BME:ECR) Must Be Happy With Their 257% Total Return

Market bids up stock over the past week

New 90-day high: €2.18

Market bids up stock over the past week

New 90-day high - €2.16

Ercros, S.A. to Report Q2, 2020 Results on Aug 31, 2020

First half earnings released

Ercros, S.A. to Report Q2, 2020 Results on Jul 31, 2020

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken